Medical Devices & Consumables
Global Intracranial Atherosclerotic Disease Treatment Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4195
- Pages: 90
- Figures: 116
- Views: 22
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The global Intracranial Atherosclerotic Disease Treatment market is projected to grow from US$ 911 million in 2024 to US$ 1474 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Intracranial Atherosclerotic Disease Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Intracranial Atherosclerotic Disease Treatment, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intracranial Atherosclerotic Disease Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Intracranial Atherosclerotic Disease Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Intracranial Atherosclerotic Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Intracranial Atherosclerotic Disease Treatment sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
TERUMO
MicroPort
Acandis
Segment by Type
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intracranial Atherosclerotic Disease Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Intracranial Atherosclerotic Disease Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intracranial Atherosclerotic Disease Treatment sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Intracranial Atherosclerotic Disease Treatment market is projected to grow from US$ 911 million in 2024 to US$ 1474 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Intracranial Atherosclerotic Disease Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Intracranial Atherosclerotic Disease Treatment, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intracranial Atherosclerotic Disease Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Intracranial Atherosclerotic Disease Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Intracranial Atherosclerotic Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Intracranial Atherosclerotic Disease Treatment sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
TERUMO
MicroPort
Acandis
Segment by Type
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intracranial Atherosclerotic Disease Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Intracranial Atherosclerotic Disease Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intracranial Atherosclerotic Disease Treatment sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Intracranial Atherosclerotic Disease Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market by Application
1.3.1 Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Estimates and Forecasts 2019-2030
2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region
2.2.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2019-2024)
2.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2025-2030)
2.2.4 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2019-2030)
2.3 Global Intracranial Atherosclerotic Disease Treatment Sales Estimates and Forecasts 2019-2030
2.4 Global Intracranial Atherosclerotic Disease Treatment Sales by Region
2.4.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2019-2024)
2.4.3 Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2025-2030)
2.4.4 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturers
3.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturers (2019-2024)
3.1.2 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intracranial Atherosclerotic Disease Treatment in 2023
3.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers
3.2.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers (2019-2024)
3.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Intracranial Atherosclerotic Disease Treatment Revenue in 2023
3.3 Global Key Players of Intracranial Atherosclerotic Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Intracranial Atherosclerotic Disease Treatment Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Product Offered and Application
3.8 Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Type
4.1.1 Global Intracranial Atherosclerotic Disease Treatment Historical Sales by Type (2019-2024)
4.1.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Sales by Type (2025-2030)
4.1.3 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
4.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Type
4.2.1 Global Intracranial Atherosclerotic Disease Treatment Historical Revenue by Type (2019-2024)
4.2.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Revenue by Type (2025-2030)
4.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Intracranial Atherosclerotic Disease Treatment Price by Type
4.3.1 Global Intracranial Atherosclerotic Disease Treatment Price by Type (2019-2024)
4.3.2 Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Application
5.1.1 Global Intracranial Atherosclerotic Disease Treatment Historical Sales by Application (2019-2024)
5.1.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Sales by Application (2025-2030)
5.1.3 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
5.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Application
5.2.1 Global Intracranial Atherosclerotic Disease Treatment Historical Revenue by Application (2019-2024)
5.2.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Revenue by Application (2025-2030)
5.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Intracranial Atherosclerotic Disease Treatment Price by Application
5.3.1 Global Intracranial Atherosclerotic Disease Treatment Price by Application (2019-2024)
5.3.2 Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Intracranial Atherosclerotic Disease Treatment Market Size by Type
6.1.1 US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2030)
6.1.2 US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2030)
6.2 US & Canada Intracranial Atherosclerotic Disease Treatment Market Size by Application
6.2.1 US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
6.2.2 US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
6.3 US & Canada Intracranial Atherosclerotic Disease Treatment Market Size by Country
6.3.1 US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
6.3.3 US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Type
7.1.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2030)
7.1.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2030)
7.2 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Application
7.2.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
7.2.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
7.3 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Country
7.3.1 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
7.3.3 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Intracranial Atherosclerotic Disease Treatment Market Size
8.1.1 China Intracranial Atherosclerotic Disease Treatment Sales (2019-2030)
8.1.2 China Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030)
8.2 China Intracranial Atherosclerotic Disease Treatment Market Size by Application
8.2.1 China Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
8.2.2 China Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Intracranial Atherosclerotic Disease Treatment Market Size by Type
9.1.1 Asia Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2030)
9.1.2 Asia Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2030)
9.2 Asia Intracranial Atherosclerotic Disease Treatment Market Size by Application
9.2.1 Asia Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
9.2.2 Asia Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
9.3 Asia Intracranial Atherosclerotic Disease Treatment Sales by Region
9.3.1 Asia Intracranial Atherosclerotic Disease Treatment Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Intracranial Atherosclerotic Disease Treatment Revenue by Region (2019-2030)
9.3.3 Asia Intracranial Atherosclerotic Disease Treatment Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Market Size by Type
10.1.1 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Market Size by Application
10.2.1 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country
10.3.1 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Stryker
11.1.1 Stryker Company Information
11.1.2 Stryker Overview
11.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Stryker Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Stryker Recent Developments
11.2 Balt
11.2.1 Balt Company Information
11.2.2 Balt Overview
11.2.3 Balt Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Balt Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Balt Recent Developments
11.3 TERUMO
11.3.1 TERUMO Company Information
11.3.2 TERUMO Overview
11.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 TERUMO Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 TERUMO Recent Developments
11.4 MicroPort
11.4.1 MicroPort Company Information
11.4.2 MicroPort Overview
11.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 MicroPort Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MicroPort Recent Developments
11.5 Acandis
11.5.1 Acandis Company Information
11.5.2 Acandis Overview
11.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Acandis Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Acandis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intracranial Atherosclerotic Disease Treatment Industry Chain Analysis
12.2 Intracranial Atherosclerotic Disease Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intracranial Atherosclerotic Disease Treatment Production Mode & Process
12.4 Intracranial Atherosclerotic Disease Treatment Sales and Marketing
12.4.1 Intracranial Atherosclerotic Disease Treatment Sales Channels
12.4.2 Intracranial Atherosclerotic Disease Treatment Distributors
12.5 Intracranial Atherosclerotic Disease Treatment Customers
13 Market Dynamics
13.1 Intracranial Atherosclerotic Disease Treatment Industry Trends
13.2 Intracranial Atherosclerotic Disease Treatment Market Drivers
13.3 Intracranial Atherosclerotic Disease Treatment Market Challenges
13.4 Intracranial Atherosclerotic Disease Treatment Market Restraints
14 Key Findings in The Global Intracranial Atherosclerotic Disease Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Intracranial Atherosclerotic Disease Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market by Application
1.3.1 Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Estimates and Forecasts 2019-2030
2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region
2.2.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2019-2024)
2.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2025-2030)
2.2.4 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2019-2030)
2.3 Global Intracranial Atherosclerotic Disease Treatment Sales Estimates and Forecasts 2019-2030
2.4 Global Intracranial Atherosclerotic Disease Treatment Sales by Region
2.4.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2019-2024)
2.4.3 Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2025-2030)
2.4.4 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturers
3.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturers (2019-2024)
3.1.2 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intracranial Atherosclerotic Disease Treatment in 2023
3.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers
3.2.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers (2019-2024)
3.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Intracranial Atherosclerotic Disease Treatment Revenue in 2023
3.3 Global Key Players of Intracranial Atherosclerotic Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Intracranial Atherosclerotic Disease Treatment Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Product Offered and Application
3.8 Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Type
4.1.1 Global Intracranial Atherosclerotic Disease Treatment Historical Sales by Type (2019-2024)
4.1.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Sales by Type (2025-2030)
4.1.3 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
4.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Type
4.2.1 Global Intracranial Atherosclerotic Disease Treatment Historical Revenue by Type (2019-2024)
4.2.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Revenue by Type (2025-2030)
4.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Intracranial Atherosclerotic Disease Treatment Price by Type
4.3.1 Global Intracranial Atherosclerotic Disease Treatment Price by Type (2019-2024)
4.3.2 Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Application
5.1.1 Global Intracranial Atherosclerotic Disease Treatment Historical Sales by Application (2019-2024)
5.1.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Sales by Application (2025-2030)
5.1.3 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
5.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Application
5.2.1 Global Intracranial Atherosclerotic Disease Treatment Historical Revenue by Application (2019-2024)
5.2.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Revenue by Application (2025-2030)
5.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Intracranial Atherosclerotic Disease Treatment Price by Application
5.3.1 Global Intracranial Atherosclerotic Disease Treatment Price by Application (2019-2024)
5.3.2 Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Intracranial Atherosclerotic Disease Treatment Market Size by Type
6.1.1 US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2030)
6.1.2 US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2030)
6.2 US & Canada Intracranial Atherosclerotic Disease Treatment Market Size by Application
6.2.1 US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
6.2.2 US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
6.3 US & Canada Intracranial Atherosclerotic Disease Treatment Market Size by Country
6.3.1 US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
6.3.3 US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Type
7.1.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2030)
7.1.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2030)
7.2 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Application
7.2.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
7.2.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
7.3 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Country
7.3.1 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
7.3.3 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Intracranial Atherosclerotic Disease Treatment Market Size
8.1.1 China Intracranial Atherosclerotic Disease Treatment Sales (2019-2030)
8.1.2 China Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030)
8.2 China Intracranial Atherosclerotic Disease Treatment Market Size by Application
8.2.1 China Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
8.2.2 China Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Intracranial Atherosclerotic Disease Treatment Market Size by Type
9.1.1 Asia Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2030)
9.1.2 Asia Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2030)
9.2 Asia Intracranial Atherosclerotic Disease Treatment Market Size by Application
9.2.1 Asia Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
9.2.2 Asia Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
9.3 Asia Intracranial Atherosclerotic Disease Treatment Sales by Region
9.3.1 Asia Intracranial Atherosclerotic Disease Treatment Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Intracranial Atherosclerotic Disease Treatment Revenue by Region (2019-2030)
9.3.3 Asia Intracranial Atherosclerotic Disease Treatment Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Market Size by Type
10.1.1 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Market Size by Application
10.2.1 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country
10.3.1 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Stryker
11.1.1 Stryker Company Information
11.1.2 Stryker Overview
11.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Stryker Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Stryker Recent Developments
11.2 Balt
11.2.1 Balt Company Information
11.2.2 Balt Overview
11.2.3 Balt Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Balt Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Balt Recent Developments
11.3 TERUMO
11.3.1 TERUMO Company Information
11.3.2 TERUMO Overview
11.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 TERUMO Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 TERUMO Recent Developments
11.4 MicroPort
11.4.1 MicroPort Company Information
11.4.2 MicroPort Overview
11.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 MicroPort Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MicroPort Recent Developments
11.5 Acandis
11.5.1 Acandis Company Information
11.5.2 Acandis Overview
11.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Acandis Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Acandis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intracranial Atherosclerotic Disease Treatment Industry Chain Analysis
12.2 Intracranial Atherosclerotic Disease Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intracranial Atherosclerotic Disease Treatment Production Mode & Process
12.4 Intracranial Atherosclerotic Disease Treatment Sales and Marketing
12.4.1 Intracranial Atherosclerotic Disease Treatment Sales Channels
12.4.2 Intracranial Atherosclerotic Disease Treatment Distributors
12.5 Intracranial Atherosclerotic Disease Treatment Customers
13 Market Dynamics
13.1 Intracranial Atherosclerotic Disease Treatment Industry Trends
13.2 Intracranial Atherosclerotic Disease Treatment Market Drivers
13.3 Intracranial Atherosclerotic Disease Treatment Market Challenges
13.4 Intracranial Atherosclerotic Disease Treatment Market Restraints
14 Key Findings in The Global Intracranial Atherosclerotic Disease Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Stent
Table 3. Major Manufacturers of PTA Balloon
Table 4. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2019-2024)
Table 9. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2025-2030)
Table 10. Global Intracranial Atherosclerotic Disease Treatment Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2019-2024) & (K Units)
Table 12. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2025-2030) & (K Units)
Table 13. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2019-2024)
Table 14. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2025-2030)
Table 15. Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Manufacturers (2019-2024)
Table 17. Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Intracranial Atherosclerotic Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Intracranial Atherosclerotic Disease Treatment Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Intracranial Atherosclerotic Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Intracranial Atherosclerotic Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Atherosclerotic Disease Treatment as of 2023)
Table 23. Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Product Offered and Application
Table 25. Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 28. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 29. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2019-2024)
Table 30. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2025-2030)
Table 31. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2019-2024)
Table 34. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2025-2030)
Table 35. Intracranial Atherosclerotic Disease Treatment Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 38. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 39. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2019-2024)
Table 40. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2025-2030)
Table 41. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2019-2024)
Table 44. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2025-2030)
Table 45. Intracranial Atherosclerotic Disease Treatment Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 60. Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 61. Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 62. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 65. Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 66. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 72. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 73. China Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 74. China Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 75. China Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 78. China Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 79. China Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 82. Asia Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 83. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 86. Asia Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 87. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Intracranial Atherosclerotic Disease Treatment Sales by Region (2019-2024) & (K Units)
Table 93. Asia Intracranial Atherosclerotic Disease Treatment Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 107. Stryker Company Information
Table 108. Stryker Description and Major Businesses
Table 109. Stryker Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Stryker Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Stryker Recent Developments
Table 112. Balt Company Information
Table 113. Balt Description and Major Businesses
Table 114. Balt Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Balt Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Balt Recent Developments
Table 117. TERUMO Company Information
Table 118. TERUMO Description and Major Businesses
Table 119. TERUMO Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. TERUMO Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. TERUMO Recent Developments
Table 122. MicroPort Company Information
Table 123. MicroPort Description and Major Businesses
Table 124. MicroPort Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. MicroPort Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MicroPort Recent Developments
Table 127. Acandis Company Information
Table 128. Acandis Description and Major Businesses
Table 129. Acandis Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Acandis Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Acandis Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Intracranial Atherosclerotic Disease Treatment Distributors List
Table 135. Intracranial Atherosclerotic Disease Treatment Customers List
Table 136. Intracranial Atherosclerotic Disease Treatment Market Trends
Table 137. Intracranial Atherosclerotic Disease Treatment Market Drivers
Table 138. Intracranial Atherosclerotic Disease Treatment Market Challenges
Table 139. Intracranial Atherosclerotic Disease Treatment Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Intracranial Atherosclerotic Disease Treatment Product Picture
Figure 2. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Intracranial Atherosclerotic Disease Treatment Market Share by Type in 2023 & 2030
Figure 4. Stent Product Picture
Figure 5. PTA Balloon Product Picture
Figure 6. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Intracranial Atherosclerotic Disease Treatment Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Intracranial Atherosclerotic Disease Treatment Report Years Considered
Figure 12. Global Intracranial Atherosclerotic Disease Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Intracranial Atherosclerotic Disease Treatment Revenue 2019-2030 (US$ Million)
Figure 14. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2019-2030)
Figure 16. Global Intracranial Atherosclerotic Disease Treatment Sales 2019-2030 ((K Units)
Figure 17. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 19. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 21. Europe Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 23. China Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 25. Asia (excluding China) Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 27. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Intracranial Atherosclerotic Disease Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Intracranial Atherosclerotic Disease Treatment in the World: Market Share by Intracranial Atherosclerotic Disease Treatment Revenue in 2023
Figure 30. Global Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 32. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 33. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 34. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 38. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2019-2030)
Figure 40. US & Canada Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2019-2030)
Figure 41. U.S. Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 44. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 45. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 46. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 47. Europe Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2019-2030)
Figure 48. Europe Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2019-2030)
Figure 49. Germany Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 50. France Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 54. China Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 55. China Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 56. China Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 57. China Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 58. Asia Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 59. Asia Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 60. Asia Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 61. Asia Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 62. Asia Intracranial Atherosclerotic Disease Treatment Revenue Share by Region (2019-2030)
Figure 63. Asia Intracranial Atherosclerotic Disease Treatment Sales Share by Region (2019-2030)
Figure 64. Japan Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 68. India Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2019-2030)
Figure 75. Brazil Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 80. Intracranial Atherosclerotic Disease Treatment Value Chain
Figure 81. Intracranial Atherosclerotic Disease Treatment Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Table 1. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Stent
Table 3. Major Manufacturers of PTA Balloon
Table 4. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2019-2024)
Table 9. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2025-2030)
Table 10. Global Intracranial Atherosclerotic Disease Treatment Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2019-2024) & (K Units)
Table 12. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2025-2030) & (K Units)
Table 13. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2019-2024)
Table 14. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2025-2030)
Table 15. Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Manufacturers (2019-2024)
Table 17. Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Intracranial Atherosclerotic Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Intracranial Atherosclerotic Disease Treatment Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Intracranial Atherosclerotic Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Intracranial Atherosclerotic Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Atherosclerotic Disease Treatment as of 2023)
Table 23. Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Product Offered and Application
Table 25. Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 28. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 29. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2019-2024)
Table 30. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2025-2030)
Table 31. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2019-2024)
Table 34. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2025-2030)
Table 35. Intracranial Atherosclerotic Disease Treatment Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 38. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 39. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2019-2024)
Table 40. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2025-2030)
Table 41. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2019-2024)
Table 44. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2025-2030)
Table 45. Intracranial Atherosclerotic Disease Treatment Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Intracranial Atherosclerotic Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 60. Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 61. Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 62. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 65. Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 66. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 72. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 73. China Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 74. China Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 75. China Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 78. China Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 79. China Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 82. Asia Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 83. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 86. Asia Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 87. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Intracranial Atherosclerotic Disease Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Intracranial Atherosclerotic Disease Treatment Sales by Region (2019-2024) & (K Units)
Table 93. Asia Intracranial Atherosclerotic Disease Treatment Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 107. Stryker Company Information
Table 108. Stryker Description and Major Businesses
Table 109. Stryker Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Stryker Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Stryker Recent Developments
Table 112. Balt Company Information
Table 113. Balt Description and Major Businesses
Table 114. Balt Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Balt Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Balt Recent Developments
Table 117. TERUMO Company Information
Table 118. TERUMO Description and Major Businesses
Table 119. TERUMO Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. TERUMO Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. TERUMO Recent Developments
Table 122. MicroPort Company Information
Table 123. MicroPort Description and Major Businesses
Table 124. MicroPort Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. MicroPort Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MicroPort Recent Developments
Table 127. Acandis Company Information
Table 128. Acandis Description and Major Businesses
Table 129. Acandis Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Acandis Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Acandis Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Intracranial Atherosclerotic Disease Treatment Distributors List
Table 135. Intracranial Atherosclerotic Disease Treatment Customers List
Table 136. Intracranial Atherosclerotic Disease Treatment Market Trends
Table 137. Intracranial Atherosclerotic Disease Treatment Market Drivers
Table 138. Intracranial Atherosclerotic Disease Treatment Market Challenges
Table 139. Intracranial Atherosclerotic Disease Treatment Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Intracranial Atherosclerotic Disease Treatment Product Picture
Figure 2. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Intracranial Atherosclerotic Disease Treatment Market Share by Type in 2023 & 2030
Figure 4. Stent Product Picture
Figure 5. PTA Balloon Product Picture
Figure 6. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Intracranial Atherosclerotic Disease Treatment Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Intracranial Atherosclerotic Disease Treatment Report Years Considered
Figure 12. Global Intracranial Atherosclerotic Disease Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Intracranial Atherosclerotic Disease Treatment Revenue 2019-2030 (US$ Million)
Figure 14. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2019-2030)
Figure 16. Global Intracranial Atherosclerotic Disease Treatment Sales 2019-2030 ((K Units)
Figure 17. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 19. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 21. Europe Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 23. China Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 25. Asia (excluding China) Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales YoY (2019-2030) & (K Units)
Figure 27. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Intracranial Atherosclerotic Disease Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Intracranial Atherosclerotic Disease Treatment in the World: Market Share by Intracranial Atherosclerotic Disease Treatment Revenue in 2023
Figure 30. Global Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 32. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 33. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 34. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 38. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2019-2030)
Figure 40. US & Canada Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2019-2030)
Figure 41. U.S. Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 44. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 45. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 46. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 47. Europe Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2019-2030)
Figure 48. Europe Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2019-2030)
Figure 49. Germany Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 50. France Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 54. China Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 55. China Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 56. China Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 57. China Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 58. Asia Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 59. Asia Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 60. Asia Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 61. Asia Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 62. Asia Intracranial Atherosclerotic Disease Treatment Revenue Share by Region (2019-2030)
Figure 63. Asia Intracranial Atherosclerotic Disease Treatment Sales Share by Region (2019-2030)
Figure 64. Japan Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 68. India Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2019-2030)
Figure 75. Brazil Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Intracranial Atherosclerotic Disease Treatment Revenue (2019-2030) & (US$ Million)
Figure 80. Intracranial Atherosclerotic Disease Treatment Value Chain
Figure 81. Intracranial Atherosclerotic Disease Treatment Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Tetrabenzyl Thiuram Disulfide Market Research Report 2025
Aug 04, 25
Global Diammonium Phosphate Fertilizer Market Research Report 2025
Aug 04, 25
Global Calcium Nitrate Fertilizer Market Research Report 2025
Aug 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232